316 related articles for article (PubMed ID: 8356982)
21. Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.
Kleiner GI; Giclas P; Stadtmauer G; Cunningham-Rundles C
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):461-4. PubMed ID: 11345293
[TBL] [Abstract][Full Text] [Related]
22. C1-INH defect as an example of deficiency disease.
Madaliński K; Sabbouh K; Chorazykiewicz M; Gregorek H
Immunol Invest; 1991 Apr; 20(2):133-41. PubMed ID: 1864632
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol.
Pappalardo E; Zingale LC; Cicardi M
Immunol Lett; 2003 May; 86(3):271-6. PubMed ID: 12706530
[TBL] [Abstract][Full Text] [Related]
24. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration.
Späth PJ; Wüthrich B; Bütler R
Complement; 1984; 1(3):147-59. PubMed ID: 6443347
[TBL] [Abstract][Full Text] [Related]
25. [Hereditary angioedema. Effect of danazol on C4 and functional C1INH].
Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
Rev Alerg Mex (1987); 1989; 36(3):99-104. PubMed ID: 2772500
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune angioedema: a new role for autoantibody in disease pathogenesis.
Jackson J; Feighery C
Autoimmunity; 1990; 7(2-3):181-7. PubMed ID: 2104184
[TBL] [Abstract][Full Text] [Related]
27. Pathogenetic and clinical aspects of C1 inhibitor deficiency.
Cicardi M; Bergamaschini L; Cugno M; Beretta A; Zingale LC; Colombo M; Agostoni A
Immunobiology; 1998 Aug; 199(2):366-76. PubMed ID: 9777420
[TBL] [Abstract][Full Text] [Related]
28. Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.
Valle SOR; Alonso MLO; Dortas Junior SD; Goudouris ES; de Carvalho ALRB; Capelo AV; Mansour E; Bernardes AF; Leite LFB; Giavina-Bianchi P; Aun MV; Ferriani MPL; Arruda LK; Grumach AS
Int Arch Allergy Immunol; 2022; 183(5):572-577. PubMed ID: 35325890
[TBL] [Abstract][Full Text] [Related]
29. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
30. Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.
Wonnaparhown A; Stefanovic A; Lugar P; Hostetler HP
Clin Exp Immunol; 2021 Dec; 206(3):378-383. PubMed ID: 34586637
[TBL] [Abstract][Full Text] [Related]
31. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.
Cicardi M; Beretta A; Colombo M; Gioffré D; Cugno M; Agostoni A
Clin Exp Immunol; 1996 Dec; 106(3):475-80. PubMed ID: 8973615
[TBL] [Abstract][Full Text] [Related]
32. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
Bork K; Staubach-Renz P; Hardt J
Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
[TBL] [Abstract][Full Text] [Related]
33. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.
Bork K; Witzke G
J Allergy Clin Immunol; 1989 Mar; 83(3):677-82. PubMed ID: 2926086
[TBL] [Abstract][Full Text] [Related]
34. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.
Chevailler A; Arlaud G; Ponard D; Pernollet M; Carrère F; Renier G; Drouet M; Hurez D; Gardais J
J Allergy Clin Immunol; 1996 Apr; 97(4):998-1008. PubMed ID: 8655897
[TBL] [Abstract][Full Text] [Related]
35. Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.
Ferriani MPL; Trevisan-Neto O; Costa JS; Melo JML; Moreno AS; Dias MM; Garibaldi PMM; Pereira GC; Chahud F; Traina F; Arruda LK
Int Arch Allergy Immunol; 2020; 181(12):941-946. PubMed ID: 32894844
[TBL] [Abstract][Full Text] [Related]
36. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
37. Chapter 22: Hereditary and acquired angioedema.
Georgy MS; Pongracic JA
Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
[TBL] [Abstract][Full Text] [Related]
38. Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors.
Fabiani JE; Paulin P; Simkin G; Leoni J; Palombarani S; Squiquera L
Ann Allergy; 1990 Apr; 64(4):388-92. PubMed ID: 2108593
[TBL] [Abstract][Full Text] [Related]
39. Acquired C1 Inhibitor Deficiency.
Otani IM; Banerji A
Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
[TBL] [Abstract][Full Text] [Related]
40. Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.
Ponce IM; Caballero T; Reche M; Piteiro AB; López-Serrano MC; Fontán G; López-Trascasa M
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):632-7. PubMed ID: 12086372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
